Real-World Effectiveness of Tirzepatide among People with Obesity or Overweight without Type 2 Diabetes (T2D)

被引：1
|
作者：
Hankosky, Emily R.
Desai, Karishma
Chinthammit, Chanadda
Grabner, Michael
Stockbower, Grace
He, Xuanyao
Mojdami, Donna
Wenziger, Cachet
Gibble, Theresa Hunter
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-2084-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2084-LB
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inflammatory biomarkers in people treated with tirzepatide living with overweight or obesity, without and with T2D: a post-hoc analysis from SURMOUNT-1 and SURMOUNT-2
    Sattar, Naveed
    Verma, Subodh
    Sourij, Harald
    Wilson, Jonathan
    Stefanski, Adam
    Zhang, Xiaotian
    Griffin, Ryan
    Ruotolo, Giacomo
    Linetzky, Bruno
    CIRCULATION, 2024, 150
  • [22] Correction to "Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus"
    Kelly, M. S.
    Scopelliti, E. M.
    Goodson, K. E.
    Lo, C. M. A.
    Nguyen, H. X.
    Simon, B.
    DIABETES OBESITY & METABOLISM, 2024,
  • [23] Improved Glycemic Control in People with Type 2 Diabetes (T2D) Initiating or Switching to Insulin Degludec/Insulin Aspart (IDegAsp) in a Real-World Setting in China
    Guo, Lixin
    Chen, Liming
    Zhao, Fan
    Liu, Xiao Y.
    Ding, Hongcheng
    Wang, Kun
    Xing, Zhong
    Shankarappa, Vinay Babu
    Chaudhary, Gaurav
    DIABETES, 2024, 73
  • [24] Predicting significant hepatic steatosis fromroutine biochemistry in people with and without type 2 diabetes (T2D)
    Nowak, Magdalena
    Dennis, Andrea
    Brears, Helena Thomaides
    Banerjee, Rajarshi
    Cusi, Kenneth
    Alkhouri, Naim
    Cuthbertson, Daniel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S542 - S542
  • [25] DISCOVER-A Global Study Program to Assess Real-World Evidence on Treatment and Outcomes of Patients with Type 2 Diabetes (T2D)
    Ji, Linong
    Charbonnel, Bernard
    Cook, William
    Fenici, Peter
    Garcia-Sanchez, Ricardo
    Gomes, Marilia B.
    Hammar, Niklas
    Hashigami, Kiyoshi
    Khunti, Kamlesh
    Nicolucci, Antonio
    Shestakova, Marina V.
    Shimomura, Iichiro
    Surmont, Filip Ame
    Medina, Jesus
    DIABETES, 2015, 64 : A692 - A692
  • [26] EFFECTIVENESS OF MY DOSE COACH (MDC) USE DURING BASAL INSULIN (BI) TITRATION IN TYPE 2 DIABETES (T2D): REAL-WORLD DATA FROM COLOMBIA
    Gomez, A.
    Ramirez Rincon, A.
    Feriz, K.
    Salamanca-Carrillo, C.
    Silva Gomez, L.
    Gandhi, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A173 - A173
  • [27] Clinical Characteristics and Dosing Patterns of Tirzepatide among Adults without Type 2 Diabetes-Real-World Results
    Gibble, Theresa Hunter
    Chinthammit, Chanadda
    Ward, Jennifer
    Cappell, Katherine
    Sedgley, Robert
    Bonafede, Mac
    Liao, Birong
    Hankosky, Emily R.
    DIABETES, 2024, 73
  • [28] Sex differences in the influence of type 2 diabetes (T2D)-related genes, parental history of T2D, and obesity on T2D development: a case–control study
    Jaime Berumen
    Lorena Orozco
    Héctor Gallardo-Rincón
    Fernando Rivas
    Elizabeth Barrera
    Rosa E. Benuto
    Humberto García-Ortiz
    Melissa Marin-Medina
    Eligia Juárez-Torres
    Anabel Alvarado-Silva
    Espiridión Ramos-Martinez
    Luis Alberto MartÍnez-Juárez
    Julieta Lomelín-Gascón
    Alejandra Montoya
    Janinne Ortega-Montiel
    Diego-Abelardo Alvarez-Hernández
    Jorge Larriva-Shad
    Roberto Tapia-Conyer
    Biology of Sex Differences, 14
  • [29] Real-world efficacy of tirzepatide in patients with heart failure without diabetes
    Augusto Jr, Silvio Nunes
    Kaelber, David
    Tang, W. H. Wilson
    CURRENT PROBLEMS IN CARDIOLOGY, 2025, 50 (04)
  • [30] Predictive Factors for Achieving Glycemic Control in People with Type 2 Diabetes (T2D) in Real Clinical Practice
    Chaudhury, Tirthankar
    Al Mansari, Abdulqawi
    Obeid, Youssef
    Islam, Najamul
    Fariduddin, Mohammed
    Hassoun, Ahmed
    Djaballah, Khier
    Malek, Mojtaba
    DIABETES, 2017, 66 : A615 - A616
12345